Healthy adults and pediatric subjects
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Signed the Informed Consent Form (ICF) 2) Diagnosed by the principal investigator (or co-investigator) as having the ability to comply with the research protocol 3) Male 4) Age >=8 and =135 and =8 and <16 years, an assent form has been signed 7) For minor research subjects aged <18 years, the ICF has been signed by the subject's legal representative
Exclusion criteria
Exclusion criteria: 1) Individuals who are deemed unable to perform the required movement tasks based on clinically significant medical history, surgical history, and history of lower limb injuries 2) Individuals with a history of skin allergic reactions or contact dermatitis, or those with skin hypersensitivity 3) Individuals with cardiac pacemakers 4) Individuals deemed inappropriate for study participation by the principal investigator (or co-investigator)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Kinetic parameters: Moments at the hip, knee, and ankle joints Power at the hip, knee, and ankle joints Work done at the hip, knee, and ankle joints Joint forces at the hip, knee, and ankle joints | — |
Secondary
| Measure | Time frame |
|---|---|
| Kinematic parameters: Joint angles of the hip, knee, and ankle joints Angular velocity of the hip, knee, and ankle joints Angular acceleration of the hip, knee, and ankle joints | — |
Contacts
Chugai Pharmaceutical Co., Ltd.